These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7035953)

  • 41. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
    Wu B; Mao J; Shen H; Fu H; Wang J; Liu A; Gu W; Shu Q; Du L
    Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The use of chlorambucil in the nephrotic syndrome (NS) with frequent recurrences in children].
    Ciardi MR; Ginevri F; Perfumo F; Gusmano R
    Minerva Nefrol; 1979; 26(4):495-600. PubMed ID: 542219
    [No Abstract]   [Full Text] [Related]  

  • 43. Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome.
    Kemper MJ; Altrogge H; Ludwig K; Timmermann K; Müller-Wiefel DE
    Pediatr Nephrol; 2000 Aug; 14(8-9):772-5. PubMed ID: 10955925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclophosphamide in the treatment of idiopathic nephrotic syndrome.
    Pennisi AJ; Grushkin CM; Lieberman E
    Pediatrics; 1976 Jun; 57(6):948-51. PubMed ID: 934751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study.
    Borovitz Y; Alfandary H; Haskin O; Levi S; Kaz S; Davidovits M; Dagan A
    Eur J Pediatr; 2020 Feb; 179(2):279-283. PubMed ID: 31728673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of treatment methods on frequency of relapse in nephrotic syndrome in children].
    Goszczyk A; Jung A; Bochniewska V; Straz-Zebrowska E
    Pol Merkur Lekarski; 2000 Sep; 9 Suppl 1():25-6. PubMed ID: 11081338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.
    Lancet; 1974 Aug; 2(7878):423-7. PubMed ID: 4137139
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunoregulation with levamisole in children with frequently relapsing steroid responsive nephrotic syndrome.
    Drachman R; Schlesinger M; Alon U; Mor J; Etzioni A; Shapira H; Ohali M; Drukker A
    Acta Paediatr Scand; 1988 Sep; 77(5):721-6. PubMed ID: 3059754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy.
    Garin EH; Pryor ND; Fennell RS; Richard GA
    J Pediatr; 1978 Feb; 92(2):304-8. PubMed ID: 621614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook.
    Vester U; Kranz B; Zimmermann S; Hoyer PF
    Pediatr Nephrol; 2003 Jul; 18(7):661-4. PubMed ID: 12750975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of different regimens of prednisone therapy in frequently relapsing nephrotic syndrome.
    Wingen AM; Müller-Wiefel DE; Schärer K
    Acta Paediatr Scand; 1990 Mar; 79(3):305-10. PubMed ID: 2333744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chlorambucil in steroid-dependent nephrotic syndrome.
    Penso JS; Olson DL; Robillard J; Smith FG
    J Pediatr; 1973 Sep; 83(3):508-9. PubMed ID: 4725161
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacological treatment of nephrotic syndrome.
    Gauthier B; Trachtman H
    Drugs Today (Barc); 1999 Jan; 35(1):13-26. PubMed ID: 12973405
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Nephrotic syndrome due to primary renal disease. Study of therapeutic response (author's transl)].
    Casado S; Ruilope LM; Oliva H; Hernando L
    An Esp Pediatr; 1974; 7(2):124-30. PubMed ID: 4849232
    [No Abstract]   [Full Text] [Related]  

  • 56. How to manage a child with steroid-responsive nephrotic syndrome when dose of prednisolone is reduced or when placed on high-dose alternate day steroids.
    Niaudet P
    Pediatr Nephrol; 1992 Nov; 6(6):522. PubMed ID: 1482637
    [No Abstract]   [Full Text] [Related]  

  • 57. The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies.
    Brodehl J
    Eur J Pediatr; 1991 Apr; 150(6):380-7. PubMed ID: 2040345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome.
    Rüth EM; Kemper MJ; Leumann EP; Laube GF; Neuhaus TJ
    J Pediatr; 2005 Aug; 147(2):202-7. PubMed ID: 16126050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N; Kim S; Craig J; Hodson E
    Arch Dis Child; 2016 Apr; 101(4):404-8. PubMed ID: 26289063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Multicenter study on present status of diagnosis and treatment of steroid-resistant nephrotic syndrome in children].
    Subspecialty Group Of Nephrology, The Society Of Pediatrics Chinese Medical Association
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):483-7. PubMed ID: 25224050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.